⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL29203898 | 1.00 | — | — | |
| Fluoride SCHEMBL5706468 | 1.00 | — | — | |
| Fluoride SCHEMBL4246866 | 1.00 | — | — | |
| Fluoride SCHEMBL35954 | 1.00 | — | — | |
| Fluoride SCHEMBL21629483 | 1.00 | — | — | |
| Fluoride SCHEMBL9116839 | 1.00 | — | — | |
| Fluoride SCHEMBL372355 | 1.00 | — | — | |
| Fluoride SCHEMBL16694049 | 1.00 | — | — | |
| Fluoride SCHEMBL9244503 | 1.00 | — | — | |
| Fluoride SCHEMBL28698758 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3826619-A1 | PHARMACEUTICAL DOSAGE FORM WHICH CAN BE ADMINISTERED ORALLY AND HAS MODIFIED RELEASE | Bayer Aktiengesellschaft (DE) | 2021-06-02 | — | — | EP | disclosed |
| EP-3826627-A1 | PHARMACEUTICAL DOSAGE FORM WHICH CAN BE ADMINISTERED ORALLY AND HAS MODIFIED RELEASE | Bayer Aktiengesellschaft (DE) | 2021-06-02 | — | — | EP | disclosed |
| WO-2020020789-A1 | PHARMACEUTICAL DOSAGE FORM WHICH CAN BE ADMINISTERED ORALLY AND HAS MODIFIED RELEASE | BAYER AKTIENGESELLSCHAFT (DE) | 2020-01-30 | — | — | WO | disclosed |
| WO-2020020790-A1 | PHARMACEUTICAL DOSAGE FORM WHICH CAN BE ADMINISTERED ORALLY AND HAS MODIFIED RELEASE | BAYER AKTIENGESELLSCHAFT (DE) | 2020-01-30 | — | — | WO | disclosed |